Loading...
Rhoen-Klinikum AG
RHK.DE•XETRA
Healthcare
Medical - Care Facilities
€11.90
€0.20(1.71%)
Rhoen-Klinikum AG (RHK.DE) Financial Performance & Statements
Review Rhoen-Klinikum AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-8.02%
↓ 8.02%
Operating Income Growth
19.18%
↑ 19.18%
Net Income Growth
11.98%
↑ 11.98%
Operating Cash Flow Growth
17.06%
↑ 17.06%
Operating Margin
2.84%
↑ 2.84%
Gross Margin
27.12%
↑ 27.12%
Net Profit Margin
2.44%
↑ 2.44%
ROE
3.08%
↑ 3.08%
ROIC
3.16%
↑ 3.16%
Rhoen-Klinikum AG (RHK.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Rhoen-Klinikum AG stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $424.57M | $395.54M | $392.69M | $382.82M |
| Cost of Revenue | $249.06M | $389.80M | $406.98M | $403.95M |
| Gross Profit | $175.51M | $5.74M | -$14.29M | -$21.13M |
| Gross Profit Ratio | $0.41 | $0.01 | -$0.04 | -$0.06 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $255.49M | $0.00 | $41.86M |
| Operating Expenses | $156.82M | $250.35M | -$22.90M | -$31.09M |
| Total Costs & Expenses | $405.88M | $384.66M | $384.08M | $372.86M |
| Interest Income | $2.46M | $1.13M | $3.64M | $3.88M |
| Interest Expense | $942000.00 | $820000.00 | $809000.00 | $829000.00 |
| Depreciation & Amortization | $16.98M | $15.15M | $15.31M | $15.18M |
| EBITDA | $38.17M | $27.20M | $23.92M | $25.14M |
| EBITDA Ratio | $0.09 | $0.07 | $0.06 | $0.07 |
| Operating Income | $18.69M | $10.88M | $8.61M | $9.96M |
| Operating Income Ratio | $0.04 | $0.03 | $0.02 | $0.03 |
| Other Income/Expenses (Net) | $1.56M | $356000.00 | $2.79M | $3.30M |
| Income Before Tax | $20.25M | $11.23M | $11.40M | $13.28M |
| Income Before Tax Ratio | $0.05 | $0.03 | $0.03 | $0.03 |
| Income Tax Expense | $5.39M | $1.44M | $1.98M | $2.18M |
| Net Income | $14.04M | $9.50M | $9.01M | $10.80M |
| Net Income Ratio | $0.03 | $0.02 | $0.02 | $0.03 |
| EPS | $0.21 | $0.14 | $0.13 | $0.16 |
| Diluted EPS | $0.21 | $0.14 | $0.13 | $0.16 |
| Weighted Avg Shares Outstanding | $66.94M | $66.94M | $66.94M | $66.94M |
| Weighted Avg Shares Outstanding (Diluted) | $66.94M | $66.94M | $66.94M | $66.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan